Replimune Group, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
REPL$22.26+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
(Amounts in thousands, except share and per share amounts)
| Three Months Ended September 30, | Six Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Operating expenses: | ||||
| Research and development | $57,877 | $43,448 | $115,721 | $86,420 |
| Selling, general and administrative | 26,414 | 15,468 | 58,994 | 29,863 |
| Total operating expenses | 84,291 | 58,916 | 174,715 | 116,283 |
| Loss from operations | (84,291) | (58,916) | (174,715) | (116,283) |
| Other income (expense): | ||||
| Research and development incentives | 377 | 408 | 797 | 846 |
| Investment income | 3,696 | 5,394 | 8,411 | 10,106 |
| Interest expense on finance lease liability | (518) | (531) | (1,039) | (1,065) |
| Interest expense on debt obligations | (1,488) | (1,438) | (2,963) | (2,864) |
| Other (expense) income, net | (876) | 2,028 | (284) | 2,433 |
| Total other income (expense), net | 1,191 | 5,861 | 4,922 | 9,456 |
| Net loss | $(83,100) | $(53,055) | $(169,793) | $(106,827) |
| Net loss per common share, basic and diluted | $(0.90) | $(0.68) | $(1.85) | $(1.45) |
| Weighted average common shares outstanding, basic and diluted | 91,915,769 | 78,570,135 | 91,717,076 | 73,903,650 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.